[1]
“EFFECT OF DAPAGLIFLOZIN, SITAGLIPTIN AND METFORMIN COMBINATION ON SOME METABLIC RISK FACTORS IN IRAQI PATIENTS WITH TYPE-2 DIABETES MELLITUS”, NPPH, vol. 22, no. 1, pp. 204–209, Jan. 2024, Accessed: Jun. 18, 2024. [Online]. Available: http://neuropsychopharmacologiahungarica.com/index.php/NPPH/article/view/17